The panel will vote Wednesday on whether the risks outweigh the benefits. The company says the tablet, Opill, is safe and easy to use but F.D.A. scientists have concerns about the data.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
